ZEPILEN

This brand name is authorized in Cyprus, Estonia, Spain, Croatia, Lithuania, Malta, Singapore

Active ingredients

The drug ZEPILEN contains one active pharmaceutical ingredient (API):

1 Cefazolin UNII IHS69L0Y4T - CEFAZOLIN

Cefazolin is a bactericidal cephalosporin antibiotic of the first generation for parenteral administration. Cephalosporins inhibit cell wall synthesis (in the growth stage) through blocking the penicillin-binding proteins (PBPs) like transpeptidases. The outcome is a bactericidal action. Read about Cefazolin

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
ZEPILEN Powder for solution for injection/infusion	Υπουργείο Υγείας (CY)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J01DB04	Cefazolin	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01D Other beta-lactam antibacterials → J01DB First-generation cephalosporins
Discover more medicines within J01DB04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1117336, 1117347, 1117358, 1117369
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 83665
Country: HR	Agencija za lijekove i medicinske proizvode	Identifier(s): HR-H-736644517
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1004989
Country: MT	Medicines Authority	Identifier(s): MA032/13001
Country: SG	Health Sciences Authority	Identifier(s): 14304P